{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:30Z","timestamp":1707524010411},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,5]]},"DOI":"10.7759\/cureus.44701","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T11:25:53Z","timestamp":1693913153000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of McArdle Disease Diagnosed Following Statin-Induced Myositis"],"prefix":"10.7759","author":[{"given":"Jo\u00e3o S","family":"Teles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina T","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz M","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anabela V","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22806","article-title":"McArdle disease: update of reported mutations and polymorphisms in the PYGM gene","volume":"36","author":"Nogales-Gadea G","year":"2015","unstructured":"Nogales-Gadea G, Brull A, Santalla A, et al.. McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat. 2015, 36:669-78. 10.1002\/humu.22806","journal-title":"Hum Mutat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235919","article-title":"McArdle disease: new insights into its underlying molecular mechanisms","volume":"20","author":"Llavero F","year":"2019","unstructured":"Llavero F, Arrazola Sastre A, Luque Montoro M, G\u00e1lvez P, Lacerda HM, Parada LA, Zugaza JL. McArdle disease: new insights into its underlying molecular mechanisms. Int J Mol Sci. 2019, 20:10.3390\/ijms20235919","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000230154.79933.d7","article-title":"Do carriers of PYGM mutations have symptoms of McArdle disease?","volume":"67","author":"Andersen ST","year":"2006","unstructured":"Andersen ST, Dun\u00f8 M, Schwartz M, Vissing J. Do carriers of PYGM mutations have symptoms of McArdle disease?. Neurology. 2006, 67:716-8. 10.1212\/01.wnl.0000230154.79933.d7","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000343002.74480.e4","article-title":"Fat metabolism during exercise in patients with McArdle disease","volume":"72","author":"\u00d8rngreen MC","year":"2009","unstructured":"\u00d8rngreen MC, Jeppesen TD, Andersen ST, et al.. Fat metabolism during exercise in patients with McArdle disease. Neurology. 2009, 72:718-24. 10.1212\/01.wnl.0000343002.74480.e4","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.04.013","article-title":"Misdiagnosis is an important factor for diagnostic delay in McArdle disease","volume":"27","author":"Scalco RS","year":"2017","unstructured":"Scalco RS, Morrow JM, Booth S, Chatfield S, Godfrey R, Quinlivan R. Misdiagnosis is an important factor for diagnostic delay in McArdle disease. Neuromuscul Disord. 2017, 27:852-5. 10.1016\/j.nmd.2017.04.013","journal-title":"Neuromuscul Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1225","article-title":"Molecular heterogeneity of myophosphorylase deficiency (mcardle's disease): a genotype\u2010phenotype correlation study","volume":"50","author":"Mart\u00edn M A","year":"2001","unstructured":"Mart\u00edn M A, Rubio J C, Buchbinder J, et al.. Molecular heterogeneity of myophosphorylase deficiency (mcardle's disease): a genotype\u2010phenotype correlation study. Ann Neurol. 2001, 50:574-81. 10.1002\/ana.1225","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20937","article-title":"Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease","volume":"37","author":"Martinuzzi A","year":"2008","unstructured":"Martinuzzi A, Liava A, Trevisi E, et al.. Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease. Muscle Nerve. 2008, 37:350-7. 10.1002\/mus.20937","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301593","article-title":"Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry","volume":"83","author":"Lucia A","year":"2012","unstructured":"Lucia A, Ruiz JR, Santalla A, et al.. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry. 2012, 83:322-8. 10.1136\/jnnp-2011-301593","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10263","article-title":"A nonischemic forearm exercise test for McArdle disease","volume":"52","author":"Kazemi-Esfarjani P","year":"2002","unstructured":"Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J. A nonischemic forearm exercise test for McArdle disease. Ann Neurol. 2002, 52:153-9. 10.1002\/ana.10263","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240612","article-title":"McArdle's disease: biochemical and molecular genetic studies","volume":"24","author":"Servidei S","year":"1988","unstructured":"Servidei S, Shanske S, Zeviani M, Lebo R, Fletterick R, DiMauro S. McArdle's disease: biochemical and molecular genetic studies. Ann Neurol. 1988, 24:774-81. 10.1002\/ana.410240612","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4439(90)90008-d","article-title":"Molecular heterogeneity in McArdle's disease","volume":"1","author":"McConchie S M","year":"1990","unstructured":"McConchie S M, Coakley J, Edwards R H T and Beynon R J. Molecular heterogeneity in McArdle's disease. Biochim Biophys Acta. 1990, 1:26-32. 10.1016\/0925-4439(90)90008-d","journal-title":"Biochim Biophys Acta"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu GD","year":"2006","unstructured":"Vladutiu GD, Simmons Z, Isackson PJ, et al.. Genetic risk factors associated with lipid-lowering drug-induced myopathies. Muscle Nerve. 2006, 34:153-62. 10.1002\/mus.20567","journal-title":"Muscle Nerve"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/157016112799305021","article-title":"Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin","volume":"10","author":"Catapano AL","year":"2012","unstructured":"Catapano AL. Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin. Curr Vasc Pharmacol. 2012, 10:257-67. 10.2174\/157016112799305021","journal-title":"Curr Vasc Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003458.pub5","article-title":"Pharmacological and nutritional treatment for McArdle disease (glycogen storage disease type V)","volume":"2014","author":"Quinlivan R","year":"2014","unstructured":"Quinlivan R, Martinuzzi A, Schoser B. Pharmacological and nutritional treatment for McArdle disease (glycogen storage disease type V). Cochrane Database Syst Rev. 2014, 2014:CD003458. 10.1002\/14651858.CD003458.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.146548","article-title":"Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity","volume":"79","author":"Andersen ST","year":"2008","unstructured":"Andersen ST, Vissing J. Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity. J Neurol Neurosurg Psychiatry. 2008, 79:1359-63. 10.1136\/adc.2008.146548","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.6.786","article-title":"Effect of oral sucrose shortly before exercise on work capacity in McArdle disease","volume":"65","author":"Andersen ST","year":"2008","unstructured":"Andersen ST, Haller RG, Vissing J. Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch Neurol. 2008, 65:786-9. 10.1001\/archneur.65.6.786","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20881","article-title":"Aerobic conditioning: an effective therapy in McArdle's disease","volume":"59","author":"Haller RG","year":"2006","unstructured":"Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol. 2006, 59:922-8. 10.1002\/ana.20881","journal-title":"Ann Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164331-a-case-report-of-mcardle-disease-diagnosed-following-statin-induced-myositis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:00Z","timestamp":1707508740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164331-a-case-report-of-mcardle-disease-diagnosed-following-statin-induced-myositis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.44701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,5]]}}}